- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Congress Must Act to Protect NJ Patients' Access
Op-ed calls for new law to ensure continued care for those with autoimmune conditions
Published on Mar. 5, 2026
Got story updates? Submit your updates here. ›
A healthcare provider in New Jersey is urging Congress to pass legislation that would protect patient access to critical treatments, especially for those with serious autoimmune disorders. The op-ed argues that without action, many patients could lose the care they rely on.
Why it matters
Access to affordable, quality healthcare is a major concern for many Americans, especially those with chronic conditions that require ongoing treatment. This op-ed highlights the potential impact on vulnerable patients if Congress fails to address this issue.
The details
The op-ed is written by a healthcare provider with locations in Freehold and Princeton, New Jersey. The author argues that patients with serious autoimmune conditions could lose access to the treatments they need if Congress does not pass new legislation to protect their care.
- The op-ed was published on March 5, 2026.
The players
New Jersey Healthcare Provider
A healthcare provider with locations in Freehold and Princeton, New Jersey who authored the op-ed.
The takeaway
This op-ed underscores the critical need for Congress to take action to safeguard healthcare access for vulnerable patients, especially those with chronic autoimmune conditions who rely on consistent, affordable treatment.




